From CLD to CDMO: A Case Study Demonstrating Successful Cell Line Technology Transfer

Thank you - Your Download is Available Below

From CLD to CDMO: A Case Study Demonstrating Successful Cell Line Technology Transfer

PDF | 1.3 MB

From CLD to CDMO: A Case Study Demonstrating Successful Cell Line Technology Transfer

Key considerations for biopharmaceutical developers and CDMOs to take your project from early CLD to an investigational new drug (IND) application include:

Strong collaboration management and communication
Confident understanding of scaling from process development to commercial production
Support in the navigation of the complex and evolving regulatory landscape
Successful technology transfer to the manufacturing facility

Clear form data

Please Complete the Form

First Name *

Last Name *

E-Mail *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

From CLD to CDMO: A Case Study Demonstrating Successful Cell Line Technology Transfer

From CLD to CDMO: A Case Study Demonstrating Successful Cell Line Technology Transfer

Please Complete the Form

Complete Form to Access the File